|
|
Volumn 2018, Issue 4, 2018, Pages
|
|
First report of parkinsonism associated with indoximod, an immune-modulating agent
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALPRAZOLAM;
CALCIUM CARBONATE;
CARBIDOPA PLUS LEVODOPA;
COLECALCIFEROL;
CYANOCOBALAMIN;
DOCETAXEL;
DOPAMINE TRANSPORTER;
FISH OIL;
IBUPROFEN;
INDOXIMOD;
ONDANSETRON;
OXYCODONE;
PRAVASTATIN;
PREDNISONE;
PROCHLORPERAZINE;
RANITIDINE;
TRIHEXYPHENIDYL;
1-METHYLTRYPTOPHAN;
TRYPTOPHAN;
ADULT;
BRADYKINESIA;
CASE REPORT;
CAUSE OF DEATH;
CLINICAL ARTICLE;
CORPUS STRIATUM;
DRUG MEGADOSE;
DRUG WITHDRAWAL;
DYSARTHRIA;
DYSPHAGIA;
FAMILY HISTORY;
FATIGUE;
FEMALE;
GAIT DISORDER;
HEART ARREST;
HUMAN;
LIMB WEAKNESS;
LOWER LIMB;
METASTATIC BREAST CANCER;
MIDDLE AGED;
MULTIPLE CYCLE TREATMENT;
MUSCLE RIGIDITY;
NOTE;
PARKINSON DISEASE;
PARKINSONISM;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;
TREMOR;
FEMALE;
HUMANS;
MIDDLE AGED;
PARKINSONIAN DISORDERS;
TRYPTOPHAN;
|
|
EID: 85053122675
PISSN: None
EISSN: 23789506
Source Type: Journal
DOI: 10.1200/JGO.2016.007492 Document Type: Note |
|
Times cited : (6)
|
|
References (5)
|
